Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is cyclosporin or tacrolimus treatment most beneficial after liver transplantation?

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 608–609 (2006)Cite this article

boxed-textMcAlister VC et al. (2006) Cyclosporin versus tacromilus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant 6: 1578–1585

Tacrolimus-based immunosuppression is associated with lower rates of rejection, graft loss, and death after liver transplantation than cyclosporin-based therapy, but at the expense of a greater risk of developing diabetes

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dousset B et al. (1998) Is acute rejection deleterious to long-term liver allograft function? J Hepatol 29: 660–668

    Article  CAS  Google Scholar 

  2. Meier-Kriesche HU et al. (2006) Immunosuppression: evolution in practice and trends, 1994–2004. Am J Transplant 6: 1111–1131

    Article  CAS  Google Scholar 

  3. Rabkin JM et al. (2001) Late mortality after orthotopic liver transplantation. Am J Surg 181: 475–479

    Article  CAS  Google Scholar 

  4. Heisel O et al. (2004) New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 4: 583–595

    Article  Google Scholar 

  5. Webster AC et al. (2005) Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 331: 810

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Medicine at the University of Birmingham, and a consultant in the Liver Unit at the Queen Elizabeth Hospital, Birmingham, UK

    James Neuberger

Authors
  1. James Neuberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James Neuberger.

Ethics declarations

Competing interests

The author has received financial support to attend meetings from both Astellas Pharma Inc and Novartis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neuberger, J. Is cyclosporin or tacrolimus treatment most beneficial after liver transplantation?. Nat Rev Gastroenterol Hepatol 3, 608–609 (2006). https://doi.org/10.1038/ncpgasthep0633

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0633

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing